echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Neurol: It is recommended to use recombinant t-PA thrombolysis before mechanical thrombus removal in acute stroke

    JAMA Neurol: It is recommended to use recombinant t-PA thrombolysis before mechanical thrombus removal in acute stroke

    • Last Update: 2021-03-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Tissue-type plasminogen activator (t-PA) can convert plasminogen into plasmin, and plasmin can degrade fibrin.


    Tissue-type plasminogen activator (t-PA) can convert plasminogen into plasmin, and plasmin can degrade fibrin.


    pixabay.


    pixabay.


    However, only about 10% of cases undergo thrombolysis with rt-PA before transplantation.


    The researchers conducted prospective observations on patients who received continuous MT treatment (from August 2018 to December 2019, obtained ethical approval from the ethics committee of the University of Würzburg, Germany, and obtained written informed consent from the patient or legal representative).


    The researchers conducted prospective observations on patients who received continuous MT treatment (from August 2018 to December 2019, obtained ethical approval from the ethics committee of the University of Würzburg, Germany, and obtained written informed consent from the patient or legal representative).


    At the end of the study, a total of 57 patients were included: 25 patients received rt-PA treatment, and 32 patients did not receive rt-PA treatment (see table) .


    The concentration of rt-PA/t-PA in the local brain during acute cerebral ischemia is unknown.


    Local brain (rt-PA/t-PA) concentration in patients with large vessel occlusion (LVO) stroke

    Local brain (rt-PA/t-PA) concentration in patients with large vessel occlusion (LVO) stroke

    This measurement showed that rt-PA can reach the ischemic blood vessel even though the collateral blood flow is completely blocked during embolization, and its concentration is similar to the systemic level.


    This measurement showed that rt-PA can reach the ischemic blood vessel even though the collateral blood flow is completely blocked during embolization, and its concentration is similar to the systemic level.


    In addition, blood sampling at the distal end of the occlusion site before recanalization has another value.


    References: Essig F, Kollikowski AM, Müllges W, et al.
    Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke.
    JAMA Neurol.
     Published online March 08, 2021.
    com/journals/jamaneurology/fullarticle/2776957" target="_blank" rel="noopener">doi:10.
    1001/jamaneurol.
    2021.
    0065 References: Essig F, Kollikowski AM, Müllges W is, the Local Cerebral et Al Recombinant Tissue Plasminogen the Activator Concentrations are an Acute During the Stroke.
    .
      JAMA Neurol.
    .
     Published Online March 08, 2021.
    com/journals/jamaneurology/fullarticle/2776957" target="_blank" rel="noopener">DOI: 10.
    1001 / jamaneurol.
    2021.
    0065 JAMA Neurol.
    .
    com/journals/jamaneurology/fullarticle/2776957" target="_blank" rel="noopener">DOI: 10.
    1001 / jamaneurol.
    2021.
    0065 in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.